Cargando…

Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors

Recently, combining histone deacetylase (HDAC) inhibitors with chemotherapeutic drugs or agents, in particular epidermal growth factor receptor (EGFR) inhibitors, is considered to be one of the most encouraging strategy to enhance the efficacy of the antineoplastic agents and decrease or avoid drug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Tarek S., Malebari, Azizah M., Mohamed, Mamdouh F. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620908/ https://www.ncbi.nlm.nih.gov/pubmed/34832959 http://dx.doi.org/10.3390/ph14111177

Ejemplares similares

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents
por: Cincinelli, Raffaella, et al.
Publicado: (2018)

Design and Synthesis of New 4-(3,4,5-Trimethoxyphenyl)Thiazole–Pyrimidine Derivatives as Potential Antiproliferative Agents
por: El-Damasy, Ashraf K., et al.
Publicado: (2023)

Design, synthesis, docking study and anticancer evaluation of new trimethoxyphenyl pyridine derivatives as tubulin inhibitors and apoptosis inducers
por: Hagras, Mohamed, et al.
Publicado: (2021)

2-(3,4,5-Trimethoxyphenyl)-1H-benzimidazole
por: Khalaji, Aliakbar Dehno, et al.
Publicado: (2008)

Naproxen Based 1,3,4-Oxadiazole Derivatives as EGFR Inhibitors: Design, Synthesis, Anticancer, and Computational Studies
por: Alam, Mohammad Mahboob, et al.
Publicado: (2021)

Novel quinoxaline derivatives as dual EGFR and COX-2 inhibitors: synthesis, molecular docking and biological evaluation as potential anticancer and anti-inflammatory agents
por: Ahmed, Eman A., et al.
Publicado: (2022)

Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors
por: Dong, Hang, et al.
Publicado: (2019)

Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors
por: Goehringer, Nils, et al.
Publicado: (2021)

Design, Synthesis, and Anticancer Activity of Novel Trimethoxyphenyl-Derived Chalcone-Benzimidazolium Salts
por: Yang, Jun-Li, et al.
Publicado: (2019)

Novel pyrrolizines bearing 3,4,5-trimethoxyphenyl moiety: design, synthesis, molecular docking, and biological evaluation as potential multi-target cytotoxic agents
por: Shawky, Ahmed M., et al.
Publicado: (2021)

5-Methoxy-1-(3,4,5-trimethoxyphenyl)-1H-indole
por: Monroe, Thomas Blake, et al.
Publicado: (2010)

2-(3,4,5-Trimethoxyphenyl)-1H-pyrrolo[2,3-b]pyridine
por: Selig, Roland, et al.
Publicado: (2009)

5-Chloro-2-(3,4,5-trimethoxyphenyl)-1,3-benzothiazole
por: Yousuf, Sammer, et al.
Publicado: (2012)

Synthesis and Biological Activity Screening of Newly Synthesized Trimethoxyphenyl-Based Analogues as Potential Anticancer Agents
por: Al-Warhi, Tarfah, et al.
Publicado: (2022)

Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect
por: Ibrahim, Tarek S., et al.
Publicado: (2021)

Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity
por: Mourad, Ahmed A E, et al.
Publicado: (2020)

(Z)-3-(1H-Indol-3-yl)-2-(3,4,5-trimethoxyphenyl)acrylonitrile
por: Penthala, Narsimha Reddy, et al.
Publicado: (2012)

(Z)-3-(1-Benzofuran-2-yl)-2-(3,4,5-trimethoxyphenyl)acrylonitrile
por: Penthala, Narsimha Reddy, et al.
Publicado: (2012)

5-(3,4,5-Trimethoxyphenyl)-1,3,4-oxadiazole-2(3H)-thione
por: Saeed, Aamer, et al.
Publicado: (2010)

1-(4-Hydroxyphenyl)-3-(3,4,5-trimethoxyphenyl)thiourea
por: Choi, Hyeong, et al.
Publicado: (2010)

Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization
por: Zayed, Mohamed F., et al.
Publicado: (2018)

(E)-1-(2-Thienyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
por: Suwunwong, Thitipone, et al.
Publicado: (2009)

(E)-1-(Pyridin-2-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
por: Fun, Hoong-Kun, et al.
Publicado: (2011)

(E)-1-(4-Bromophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
por: Suwunwong, Thitipone, et al.
Publicado: (2008)

4,4,5,5-Tetramethyl-2-(3,4,5-trimethoxyphenyl)imidazolidine-1-oxyl 3-oxide
por: Wang, Hai-Bo, et al.
Publicado: (2009)

(E)-1-(2-Furyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
por: Fun, Hoong-Kun, et al.
Publicado: (2010)

New Anticancer Theobromine Derivative Targeting EGFR(WT) and EGFR(T790M): Design, Semi-Synthesis, In Silico, and In Vitro Anticancer Studies
por: Elkaeed, Eslam B., et al.
Publicado: (2022)

The Anticancer Activity for the Bumetanide-Based Analogs via Targeting the Tumor-Associated Membrane-Bound Human Carbonic Anhydrase-IX Enzyme
por: Malebari, Azizah M., et al.
Publicado: (2020)

Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual‐Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)
por: Sinatra, Laura, et al.
Publicado: (2020)

Synthesis and Anticancer Activities of Pyrazole–Thiadiazole-Based EGFR Inhibitors
por: Kurban, Berkant, et al.
Publicado: (2023)

Synthesis, Characterization and Biological Evaluation of Novel Dihydropyranoindoles Improving the Anticancer Effects of HDAC Inhibitors
por: Bingul, Murat, et al.
Publicado: (2020)

Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole
por: Romagnoli, Romeo, et al.
Publicado: (2016)

(E)-1-(2-Aminophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
por: Chantrapromma, Suchada, et al.
Publicado: (2011)

1-(2-Chloroacetyl)-3-methyl-2,6-bis(3,4,5-trimethoxyphenyl)piperidine-4-one
por: Lakshminarayana, B. N., et al.
Publicado: (2009)

Structure based design, synthesis and activity studies of small hybrid molecules as HDAC and G9a dual inhibitors
por: Zang, Lanlan, et al.
Publicado: (2017)

Synthesis and Antiproliferative Activity of Novel Heterocyclic Indole-Trimethoxyphenyl Conjugates
por: Cahill, Michael M., et al.
Publicado: (2017)

Synthesis, Characterisation and Mechanism of Action of Anticancer 3-Fluoroazetidin-2-ones
por: Malebari, Azizah M., et al.
Publicado: (2022)

The anticancer effects of HDAC inhibitors require the immune system
por: West, Alison C, et al.
Publicado: (2014)

Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety
por: Al-Sanea, Mohammad M, et al.
Publicado: (2020)

Synthesis of New 1, 3, 4-Oxadiazole-Incorporated 1, 2, 3-Triazole Moieties as Potential Anticancer Agents Targeting Thymidylate Synthase and Their Docking Studies
por: Alam, Mohammad Mahboob, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9mdh6nmi8kohv55vvfvjbijhs5